BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  Former Puma Biotechnology Executive Sentenced to More than Two Years in Prison for Insider Trading

  Robert Gadimian, a former executive with Puma Biotechnology, was sentenced to more than two years in prison for insider trading.

  June 21, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  OxyContin Maker Purdue Pharma to Cut 350 More Jobs

  Purdue Pharma, best known for selling painkiller OxyContin, announced it laid off approximately 350 staffers.

  June 21, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  BrainStorm Considers Offering Experimental NurOwn to ALS Patients Under Right-to-Try for a Hefty Chunk of Money

  The first company has provided a potential out-of-pocket price for patients who seek access through the recently passed federal Right-to-Try legislation and it’s not cheap.

  June 21, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  A Look at 6—Count ‘em, 6!—Biotech IPOs This Week

  It’s a super-busy week for biotech initial public offerings (IPOs) with six companies raking in a total of around $568 million.

  June 21, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Genetown

  Report: Commercial Viability of Gene Therapy Treatments Remain

  A new report highlights some concerns about the long-term commercial viability of game-changing gene therapies that can radically transform the lives of patients.

  June 21, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Novo Nordisk’s Semaglutide Shows Non-Inferiority Against 2 More Diabetes Competitors

  Novo Nordisk’s semaglutide, an oral GLP-1 analogue, continues to rack up positive Phase III clinical trial data compared to its competitors.

  June 21, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Incyte Plans sNDA for Impressive Jakafi but Forced to Scrap Another Program

  Shares of Incyte Corporation are up slightly this morning after the company started off its annual R&D day with positive news from its pivotal REACH1 study of Jakafi (ruxolitinib) in steroid-refractory acute graft-versus-host disease (GVHD) and sets up the filing of a supplemental New Drug Application.

  June 21, 2018

   · 

  2 min read
• 

  Drug Development

  Massachusetts General Hospital Researcher’s Diabetes Vaccine Appears to Present Cure 8 Years Later

  Researchers at Massachusetts General Hospital in Boston published results from a long-term clinical trial of a tuberculosis vaccine in type 1 diabetes patients that in a long-term follow-up appears to have cured the disease.

  June 21, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Don’t Be Left Behind! 5 Keys to Career Development in the Workplace of the Future

  We are living in a business climate of intense change and what seems to be a constant transition. It’s hard to keep up with all that’s going on while following the latest news.

  June 21, 2018

   · 

  4 min read

   · 

  Porschia Parker
• 

  How to Develop Yourself as a Leader at Work

  We live in a time where there is no shortage of opinions, viewpoints, and advice. Due to this age of over-sharing, it’s easy to get caught up in what everyone else is doing. Are you a follower or a leader?

  June 21, 2018

   · 

  2 min read

   · 

  Porschia Parker